2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

作者：Scott M. Grundy, Neil J. Stone, Alison Bailey, Craig Beam, Kim K. Birtcher, Roger S. Blumenthal, Lynne T. Braun, Sarah D. de Ferranti, Joseph Faiella-Tommasino, Daniel E. Forman, Ronald Goldberg, Paul A. Heidenreich, Mark A. Hlatky, Daniel W. Jones, Donald M. Lloyd‐Jones, Nuria Lopez-Pajares, Chiadi E. Ndumele, Carl E. Orringer, Carmen Peralta, Joseph J. Saseen, Sidney C. Smith, Laurence Sperling, Salim S. Virani, Joseph Yeboah · 发表于：Circulation · 年份：2019 · DOI：10.1161/cir.0000000000000624 · 被引用次数：911 · 研究领域：Lipoproteins and Cardiovascular Health、Health Systems, Economic Evaluations, Quality of Life、Antiplatelet Therapy and Cardiovascular Diseases

hydroxymethylglutaryl-CoA reductase inhibitors/statins ◼ hypercholesterolemia ◼ lipids ◼ patient compliance ◼ primary prevention ◼ risk assessment ◼ risk reduction discussion ◼ risk treatment discussion, secondary prevention ◼ ezetimibe ◼ proprotein convertase subtilisin